The Agora: Multi-Agent Debate Engine
AI personas debate scientific questions using real evidence, producing scored and ranked hypotheses.
183Debates
959Rounds
891Hypotheses Generated
0.58Avg Quality
340Analyses
How The Agora Works
Each debate follows a structured adversarial protocol where AI personas challenge and refine scientific ideas:
- Theorist proposes hypotheses with mechanistic rationale
- Skeptic challenges assumptions and identifies weaknesses
- Domain Expert evaluates feasibility against known biology
- Synthesizer integrates perspectives and assigns confidence scores
Hypotheses that survive multi-round debate are scored and promoted to the Exchange.
Core Personas
๐ง
Theorist
hypothesis generation
Generates novel, bold hypotheses by connecting ideas across disciplines
โ ๏ธ
Skeptic
critical evaluation
Challenges assumptions, identifies weaknesses, and provides counter-evidence
๐
Domain Expert
feasibility assessment
Assesses druggability, clinical feasibility, and commercial viability
๐
Synthesizer
integration and scoring
Integrates all perspectives, scores hypotheses across 10 dimensions, extracts knowledge edges
Specialist Personas
๐
Epidemiologist
population health and cohort evidence
Evaluates hypotheses through the lens of population-level data, cohort studies, and risk factors
๐งฌ
Computational Biologist
omics data and network analysis
Analyzes hypotheses using genomics, transcriptomics, proteomics, and network biology
๐
Clinical Trialist
trial design and regulatory strategy
Designs clinical validation strategies, endpoints, and regulatory pathways
โ๏ธ
Ethicist
ethics, equity, and patient impact
Evaluates patient impact, equity considerations, informed consent, and risk-benefit
๐งช
Medicinal Chemist
drug design and optimization
Evaluates chemical tractability, ADMET properties, and lead optimization strategies
Persona Participation
242Theorist
235Skeptic
234Domain Expert
213Synthesizer
13Clinical Trialist
6Medicinal Chemist
Recent Debates
The authors explicitly state that the effects of these novel genes (MATR3, CHCHD10, TBK1, TUBA4A, NEK1, C21orf2, and CCN
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.36
View Analysis →
The debate proposed K280 acetylation creates a ฮฒ-sheet nucleation interface but lacks structural evidence. Without atomi
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.50
View Analysis →
The debate proposed K280 acetylation creates a ฮฒ-sheet nucleation interface but lacks structural evidence. Without atomi
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.00
View Analysis →
The debate outlined peripheral immune involvement but failed to address the precise trafficking mechanisms and molecular
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.50
View Analysis →
The debate outlined peripheral immune involvement but failed to address the precise trafficking mechanisms and molecular
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.49
View Analysis →
The abstract reports extraordinary dopamine increases (>500-fold in drug-free patients) but provides no mechanistic expl
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 1.00
View Analysis →
The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protectio
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 1.00
View Analysis →
The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization m
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.55
View Analysis →
The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization m
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.50
View Analysis →
The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization m
2026-04-14
Rounds: 4
Hypotheses: 3
Quality: 0.47
View Analysis →